In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Matrixx Eyes Antacids, Oral Care; Zicam Brand Drives 50% Sales Jump

This article was originally published in The Tan Sheet

Executive Summary

Matrixx is concentrating research spending on antacids, analgesics and oral care as possible areas for new product development

You may also be interested in...



Slow Cold Season Trims Matrixx Q4 Sales, But Net Loss Down By $2.5 Million

A slow-starting cold season contributed to an 18 percent dip in fourth-quarter sales of Matrixx Initiatives' Zicam cough/cold and flu relief products, company President and CEO Carl Johnson says

Slow Cold Season Trims Matrixx Q4 Sales, But Net Loss Down By $2.5 Million

A slow-starting cold season contributed to an 18 percent dip in fourth-quarter sales of Matrixx Initiatives' Zicam cough/cold and flu relief products, company President and CEO Carl Johnson says

Slow Cold Season Trims Matrixx Q4 Sales, But Net Loss Down By $2.5 Million

A slow-starting cold season contributed to an 18 percent dip in fourth-quarter sales of Matrixx Initiatives' Zicam cough/cold and flu relief products, company President and CEO Carl Johnson says

Related Content

Topics

UsernamePublicRestriction

Register

PS098779

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel